chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in my right arm; It shoots up into my shoulder sometimes; This is a spontaneous report received from a contactable consumer (patient) via Medical information team. A 84-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration in right arm on 17Feb2021 at single dose for COVID-19 immunization. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: unknown), via an unspecified route of administration on 17Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient stated that, about 1-2 weeks after receiving the 2nd dose I started having pain in my right arm, where I got my shot and it shoots up into my shoulder sometimes. This morning the patient stated he used my heating pad for the pain. Patient asked what should I do about this pain. Is it normal to have it weeks after the vaccine dose. It was reported that Pfizer person I was speaking to before you told me you would be able to tell me what to do about the pain and treatments. I have been on the telephone for over 90 min and don't really know any more than when I started calling. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Lower facial numbness, cheeks, lips, chin, decreased sensation similar to dental injection numbness.  Lasted about 12 hours.  I took 25mg of benadryl.
Initial misuse report received from a healthcare professional on 29 May 2013. ACTHIB was reconstituted with Merck diluent and the dose was administered. (No information was provided regarding the patient). No adverse event was reported. List of documents held by sender: none.
pt recv vax & devel chronic fatigue, double vision & numbness & tingling in face & extremities;MRI 2yr  later showed brain lesions;dx monophasic demylenating disease;nonspecific CNS disorder d/t demyelinization or small vessel ischemia
Felt pins and needles on her left arm; numbness/loss of sensation; pain from the top of her left shoulder to the tip of her fingers; second dose was not administered on the right spot-on top of shoulder; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Felt pins and needles on her left arm) and SENSORY LOSS (numbness/loss of sensation) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (no medical history reported.).   On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was not administered on the right spot-on top of shoulder). On 23-Mar-2021, the patient experienced PARAESTHESIA (Felt pins and needles on her left arm) (seriousness criterion hospitalization), SENSORY LOSS (numbness/loss of sensation) (seriousness criterion hospitalization) and PAIN IN EXTREMITY (pain from the top of her left shoulder to the tip of her fingers). The patient was hospitalized from 31-Mar-2021 to 05-Apr-2021 due to PARAESTHESIA and SENSORY LOSS. On 22-Mar-2021, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (second dose was not administered on the right spot-on top of shoulder) outcome was unknown. At the time of the report, PARAESTHESIA (Felt pins and needles on her left arm), SENSORY LOSS (numbness/loss of sensation) and PAIN IN EXTREMITY (pain from the top of her left shoulder to the tip of her fingers) outcome was unknown.            Tests were done to rule out heart attack and stroke. Electromyography (EMG) was also done. The results of the tests are unknown to the patient. She was advised to followup with her healthcare provider.  Based on the current information available and the temporal association between the product use and the start date of the events an causal relationship cannot be excluded. No information on the tests done to rule AMI or stroke is available and further information is requested.; Sender's Comments: Based on the current information available and the temporal association between the product use and the start date of the events an causal relationship cannot be excluded. No information on the tests done to rule AMI or stroke is available and further information is requested.
I had flown out of state, returned on 11/21/22, started feeling ill 11/21/22. I had a fever, headache, cough, head congestion. I thought I was getting a cold but once I developed a fever, I decided to use my home COVID-19 test that came back positive. I called my doctor who prescribed PAXLOVID, I started taking it on 11/23/22, by the third day I started to feel better. I did isolate for the five days. I did get rebound COVID-19 but without fever and it was relieved with over-the-counter cold medication. It wasn't as bad as the first week.
9:35 am Daughter stated "she spoke to her mother and she didn't answer her she had a blank stare like she was out for a second then she answered me"  Mother pt c/o of "feeling whoozy"  Assess:  When nurse arrived to vehicle pt AAO no SOB,  no LOC - N/V  VS taken 168/94, HR 80 reg, strong, Resps 18 reg non labored, SpO2 96%. daughter stated "it wasn't like a seizure, her mother doesn't take her medications correctly" No list of meds.  Changed monitor to 30 min. gave water for hydration. Pt stated anxious about getting vac. L del vac site benign. - red, - swelling. - facial swelling.  Provided reassurance Monitored VS BP elevated 178/96, 80. Advised to call primary to update, V-safe .  pt stated "I feel good now, not dizzy" after 30 min OK'd to exit.
warm; fever 101.5; fatigue; achiness all over the body; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm), PYREXIA (fever 101.5), FATIGUE (fatigue) and MYALGIA (achiness all over the body) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetic.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced FEELING HOT (warm), PYREXIA (fever 101.5), FATIGUE (fatigue) and MYALGIA (achiness all over the body). At the time of the report, FEELING HOT (warm), PYREXIA (fever 101.5), FATIGUE (fatigue) and MYALGIA (achiness all over the body) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.
felt like they had tonsillitis; still weak; stomach is sort of out of sorts; I'm constantly having floaters, referring to bowel movements; Arm pain; ongoing fatigue the past two or three weeks/ tired all of the time; fever; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLITIS (felt like they had tonsillitis), ASTHENIA (still weak), ABDOMINAL DISCOMFORT (stomach is sort of out of sorts), FLATULENCE (I'm constantly having floaters, referring to bowel movements) and PAIN IN EXTREMITY (Arm pain) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Tooth repair. Concomitant products included AMOXICILLIN for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TONSILLITIS (felt like they had tonsillitis), ASTHENIA (still weak), ABDOMINAL DISCOMFORT (stomach is sort of out of sorts), FLATULENCE (I'm constantly having floaters, referring to bowel movements), PAIN IN EXTREMITY (Arm pain), FATIGUE (ongoing fatigue the past two or three weeks/ tired all of the time) and PYREXIA (fever). At the time of the report, TONSILLITIS (felt like they had tonsillitis), PAIN IN EXTREMITY (Arm pain) and PYREXIA (fever) outcome was unknown and ASTHENIA (still weak), ABDOMINAL DISCOMFORT (stomach is sort of out of sorts), FLATULENCE (I'm constantly having floaters, referring to bowel movements) and FATIGUE (ongoing fatigue the past two or three weeks/ tired all of the time) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Body temperature: 99.6 (High) Abnormal.         Treatment medications were not provided   This case was linked to MOD-2021-214821 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jun-2021: Significant follow up received on 30-JUN-2021. Reporter phone number, salutation, email address were updated and Events like stomach discomfort, floaters/Gas, Tired and weakness were updated
Reaction occurred about 24 hours after receiving PREVNAR vaccine. Patient developed a red itchy area from injection site down to elbow area. Rash formed a line from injection area to inside of elbow. Still has rash.
This spontaneous report as received from a physician via a company representative refers to a 15 month old male patient who was born premature, at 36 weeks. On 24-JAN-2014, the patient was vaccinated with (Oka/Merck) VARIVAX lot # J004167, expiry date: 08-APR-2015) 1350 U (plaque forming units); dose: as directed (0.5ml) injection, subcutaneously. Other suspect therapies included liquid PEDVAX HIB (dose, route of administration, indication, lot#, expiry date unspecified) and INFANRIX, both given concomitantly on the same day with (Oka/Merck) VARIVAX. On 27-JAN-2014, the patient developed a 103F temperature after receipt of (Oka/Merck) VARIVAX. The patient sought medical attention by visiting the office and received the treatment: ibuprofen and acetaminophen. The patient had the urine analysis and complete blood count (CBC) testing performed (on an unspecified date with no results provided). The outcome of event was reported as recovered on 03-FEB-2014. The relatedness between event and (Oka/Merck) VARIVAX or liquid PEDVAXHIB was not reported. Additional information has been requested.
After 10 days of receiving my shot a red rash developed on my right arm. Itching, swollen, redness, no pain but mainly irritation. The manufacturer is Moderna.
Fever, Feverish, Muscle Aches, Sore Throat, Cough, Headache, Ear ache, dizziness
she was sick from her covid shot.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.   A 77 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "she was sick from her covid shot.".  Additional information: Spoke with patient prescribed Ibrance. Patient advised me that she was late taking her medication and she was sick from her covid shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
ANTHRAX Booster given on Saturday, May 14th, 2016 in the morning. By the afternoon, onset symptoms- swelling, pain, achy, feverish. By Sunday evening, moderate to severe aching pain to right arm radiating up the neck/shoulder; numbness and unable to sleep due to the pain despite Motrin 800mg prn. On Monday, the numbness and pain were improving but swelling was notable to right side of face, neck, chest and arm/shoulder. Right arm measured 4cm larger than left arm. By Tuesday, symptoms resolving.
Patient developed fever (Temperature = 100.3) and redness/swelling around vaccination site within 12 hours of administration. In past 24 hours area increased to 10cm x 7cm area of erythema/ induration with a 1.5cm cluster of vesicles. Itchy. Also developed HA and temperature = 100.3. Tx with ALRP. This is a followup report previously submitted on 5/16/2007. Information has been received from a registered nurse concerning a 5 year old male with no medical history, drug reaction or allergies who on 22 MAY 2007 was vaccinated intramuscularly into the left arm with a first of varicella virus vaccine live (oka/Merck) (Lot 01250). The patient also developed a headache, and temperature of 100.4 and was treated with acetaminophen (TYLENOL). Unspecified medical attention was sought. There was no product quality complaint. No further information is expected.
This spontaneous report as received from a pharmacist refers to a 56 years old male patient with penicillin allergy. The patient was vaccinated with the first dose of PNEUMOVAX23 intramuscularly in approximately 2009 ("about three years ago"). It was reported that the patient was administered another dose of PNEUMOVAX23 intramuscularly as well as a flu vaccine (manufacturer unknown) on 10-OCT-2012. The lot# of PNEUMOVAX23 was reported as H010661, expired date 02-FEB-2014. Concomitant medications included an antidepressant. It was reported that "same evening of 10-OCT-2012 the patient was treated in an emergency room for cellulitis." The present patient status was recovered. The date the patient recovered was unknown. No treatment information was reported. Additional information has been requested.
Approx 1/2 hour after vaccines, returned to clinic c/o tummy pain and sweating (very hot outside). Nurse practitioner listened and examined chest - breath sounds clear, no retracting, no increased respiratory effort. Approx 10 minutes later, Mom called clinic stating eyelids slightly puffy and child itching, no breathing problem but tummy still hurts. Advised to give Benadryl and call back. Approx 2 minutes later Mom called stated lips swollen and eyes more puffy (nearly shut). Mom was advised to go to local ER dept and did. ER tx Benadryl IV adm. Angioedema.
4 x 2 cm erythema with warm. Slight raised patch left anterior thigh. 2 days ago. Immunization received 04/21.
Right patch of red papular area on upper shoulder, one area w vesicular some other red area under the arm/chest. Rx: Acyclovir. Dx: shingles.
pt recv vax & w/in 24hr pt devel urticaria of moderate to severe intensity x past 6months;
With 5 minutes of receiving vaccines, child developed rash on back and legs. Vital signs stable. No respiratory distress. Benadryl given immediately. Child observed for 30 minutes. No more symptoms noted Dr and f/u appt made. No fever present, rash still present when patient left.
The pt came down with low grade fever on 03/01/2002, the next day he came down wit rash, started on stomach, now also in scalp. Also on 02/28/2002 he was given Keflex for infected left great toe, also donatussin Syrup per mom once per day on 03/03/2002 and 03/04/2002.
Fever & chills, body aches.  Onset 5 hours after injection, Lasted 24 hours.
SEVERE HEADACHE  START JUNE 26, 2021 CONTINUES OCULAR MIGRAINE START JUNE 26,2021 1015 AM END JUNE 26,1055 AM DIZZINESS SEVERE LIGHTHEADED WEAKNESS [LEGS]  NO TREATMENT.  ALL AES CONTINUE MORE THAN 30 DAYS AFTER ACCINATION
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium
I?ve had a hard time breathing since the Tuesday after. Developed a bad headache this week, and wake up with sharp head pains. I also have aches around my body.
Face  swell and eyes swell shut.  Huge bumps all over body and face.  I took pics. Throat was also feeling numb
Red bump at injection site 5 hours after vaccine.  Bump has reduced and redness reduced but 8 days later still a red bump at injection site that is now slightly itchy.
Temporary blindness for about 5-10 minutes. I was unable to see but was conscious and eyes were completely dilated. As a result of the inability to see, I felt panicky and my fingers and face were tingly.
Patient passed out on her way out of pharmacy after vaccine administration then gained consciousness complaining about feeling dizzy patient was still down and blood pressure checked.
Pt received MMR on 6/1/01. Grandmother stated on 6/3/01 pt complained of headache, temp 101-102 and nausea. On 6/4/01 there were light red raised areas on the neck and shoulders, loss of appetite, nausea, low grade temp and a headache. On 6.6.01 grandmother took child to Dr. The child was unable to see routine doctor. While seeing Dr, blood test and urine were done. The results to the blood and urine test were negative, and the doctor could not give reason for condition. On 6/8 child had red raised areas on neck, shoulders, back, chest, and arms. Blood & urine test were done again, urine came back positive with bacteria. Dizzy, headache and red spots remain. Pt taken to ER Dr diagnosed measles.
Two weeks later, she received her second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two weeks later, she received her second dose) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two weeks later, she received her second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Two weeks later, she received her second dose) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the event was not applicable   Reporter did not allow further contact
23OCT woke up w/fever of 103 & skin was red & looked sunburned;taken to MD though it was an allergic rxn to vax;
Patient came in for Moderna dose #2, (first dose done outside) was given at day #22, which was to early. First dose 3/22/2021; 2nd dose given on 4/13/2021
This spontaneous report was received from a physician and refers to a 12 month old female patient. No information regarding the patient's concurrent condition, medical history, concomitant medications and drug reactions or allergies was provided. On 16-NOV-2018, the patient was vaccinated with PROQUAD lot # R020676, expiration date 15-JAN-2020 (albumin status, exact dose and route of administration were not reported) for prophylaxis. On 20-NOV-2018, the patient experienced a fever between 102 to 105 degrees Fahrenheit. The patient was seen in the emergency room on 29-NOV-2018 and was admitted to hospital on 30-NOV-2018. The patient was found to have dehydration and a "rash on her stomach" in the hospital in 2018 (exact date unknown). The outcome of the events was reported as recovered. The relatedness between the events and PROQUAD was not reported.
Patient received a first dose on 04-aug-2021 and the second dose 23-nov-2021; This case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a 54-year-old female patient who received HAB (Twinrix) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Twinrix (1st dose received on 4th August 2021).   On 23rd November 2021, the patient received the 2nd dose of Twinrix and Twinrix Pre-Filled Syringe Device. On 23rd November 2021, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was unknown. The patient received second dose later than the recommended interval, which led to lengthening of vaccination schedule. No further events were reported. The reporter agreed to be contacted for follow-up. The Vaccine Administration Facility is the same as Primary Reporter.
Chest pain , Fever ,Shortness of breath, muscle and body  aches, Headache , paralyzed
Mom called today, 9/12/19, stating that the day after vaccination on 9/5/19 the child's right leg was very swollen the following day.  She states that it finally went down and now is left with a scaly almost bruised looking circular area to the right thigh.  I advised mom to take the child to see his PCP for evaluation.
For several days a low grade fever got worse each day.  Top temperature recorded was 102.8 using digital thermometer.  Pulse rate and blood pressure also increased.  On the worst night, April 20, pulse was 105, blood pressure was 150 over 110.  Patient also experienced extreme chills, sweating, and hallucinations.  The following day the entire body was sore and ached.  The following days the symptoms subsided but have yet to completely go away.  The other aspect is that these symptoms were not as bad in the day time as they were overnight.  The symptoms came in waves.
Treatment with Paxlovid previously in July for positive COVID - now presenting with severe shortness of breath and pulmonary infiltrates. Not candidate for remdesivir
Systemic: Dizziness / Lightheadness-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Bilateral Pulmonary Embolism-Severe
Fluctuating temp, 100.3-97.5 for 5 days, muscle weakness, body aches, unsteady on my feet, nausea, no appetite,  brain fog, extreme fatigue, for 8 days  or more. COPD so much worse that I had to use albuterol twice a day which I didn't use before lasting 2 weeks. No daily walk for 2 weeks because I couldn't balance properly. Sweats and chills not corresponding to temp fluctuation 2 weeks. Night sweats which I have never had before EVER. My scleritis kicked in really bad, worse than ever before. I still don't feel well  19 days later
Sick for 23 days...throwing up..when that stoped I had diarrhea. I was weak and lethargic. Pale in Cold and I felt like I was in a big fog. Prevented me from working. It started within 30min of the shot. I call the pharmacy multiply times thinking I was dying. He kept saying your not your fine. I wasn't fine. I couldn't think straight ..I'm still not normal.
Patient developed redness and swelling at injection site soon after receiving immunization, then over a period of the next few weeks it developed into large bumps, was ithcy and then scabbed over and turned black. Patient states as of today, it no longer hurts and is starting to heal.